Objectives-To examine the relation between coronary heart disease and the apolipoprotein E phenotypes in patients with non-insulin dependent diabetes mellitus.
Introduction
Lipoproteins are important determinants of atherosclerotic vascular disease in man. The serum concentrations and metabolism of lipoproteins are largely modulated by apolipoproteins and it has therefore been hypothesised that genetic variations in apolipoproteins are associated with the variation in the susceptibility to coronary heart disease.' Polymorphism of apolipoprotein E has recently received an increasing attention. Three common alleles, e2, e3, and e4 determine the six apolipoprotein E phenotypes E2/2, E2/3, E2/4, E3/3, E4/3, and E4/4. Low density lipoprotein metabolism is associated with the apolipoprotein E polymorphism such that subjects with the phenotypes E4/3 and E4/4 have higher concentrations and subjects with the e2 allele lower plasma concentrations of total and low density lipoprotein cholesterol than do subjects with the commonest apolipoprotein E phenotype, E3/3. [2] [3] [4] [5] Diabetic patients, particularly those with non-insulin dependent diabetes, have an increased risk of all manifestations of atherosclerotic vascular disease. 6 Although non-insulin dependent diabetes has adverse effects on serum lipoproteins and is associated with an increased incidence of hypertension and obesity, the strength of the relation between total cholesterol concentration, blood pressure, and smoking and the risk ofcoronary heart disease seems to be about the same in people with and without diabetes.6 Indeed, the major proportion of the excess of coronary heart disease in non-insulin dependent diabetic patients still remains unexplained.
The Finnish population has an extremely high prevalence of coronary heart disease, and Finland also ranks among those countries with the highest cholesterol concentrations in the world.7 Among the Finns men with non-insulin dependent diabetes from East Finland are at a particularly high risk of atherosclerosis; manifestations of coronary heart disease occur two to four times more often among them than in men without diabetes.8 Since classic risk factors do not seem to explain this excess risk8 we studied the relation between coronary heart disease and apolipoprotein E phenotypes in men with non-insulin dependent diabetes from East Finland to elucidate the role of the phenotype pattern in modulating the risk of coronary heart disease.
Subjects and methods
All diabetic patients in Finland needing drugs for diabetes are provided with them free of charge according to the Sickness Insurance Act. The Social Insurance Institution maintains a central register of all the diabetic subjects receiving drug reimbursement. From this register all diabetic subjects aged 45-64 years were identified from the population living in the district of Kuopio University Central Hospital (East Finland). The subjects were originally identified for a study of the prevalence of atherosclerotic vascular disease and its risk factors in subjects with and without diabetes.8 For the present study we randomly selected 138 of the 253 men with non-insulin dependent diabetes. All diabetic men included in the final study population fulfilled the World Health Organisation criteria for diabetes mellitus. 9 We randomly selected 64 men without diabetes, aged 45-64 years, from the population register for the district to serve as controls. The controls were thus completely representative of the non-diabetic population of the study area. Diabetes was excluded in the controls on the basis of measurements of fasting plasma glucose concentration. None of the control or diabetic men were receiving hypolipidaemic drugs and none had a significant impairment in renal function as assessed by serum creatinine concentration. The participation rate in the original study from which BMJ VOLUME 303 9 NOVEMBER 1991 these men were drawn was 79% in the control group and 81% in the diabetic group. 20 The concentration of glycated haemoglobin (normal range 5-5-8 5%; coefficient of variation 6%) was determined by commercial column chromatography (Quick-Sep fast haemoglobin test system, Isolab Akron, Ohio, United States) after incubation of blood in 0-9% saline for 12 hours. Plasma glucose concentration was measured by the glucose dehydrogenase method (Merck Diagnostica, West Germany). Patients' endogenous insulin secretion capacity was assessed after eating by measuring plasma C peptide concentration after stimulation with 1 Results Table I lists the characteristics of the study groups. Diabetic subjects were heavier, had more hypertension, and were less physically active than the control subjects. disease in control subjects were too low to allow statistical analysis. The prevalences of definite myocardial infarction and ischaemic electrocardiographic changes were highest in the subjects with the phenotypes E4/4 or E4/3 (25% and 50%, respectively), although the difference between the phenotype groups was not significant. Angina pectoris was found in 69% (25) of subjects with the phenotypes E4/4 or E4/3 (p=0 005 compared with other phenotypes) compared with 41% (35) of subjects with the phenotype E3/3 and 47% (six) of those with phenotypes E2/2 or E2/3. Similarly, the prevalence of simultaneous presence of angina pectoris and ischaemic electrocardiographic changes was higher (42%) in subjects with phenotypes E4/4 or E4/3 than in those with other phenotypes (E3/3 22%; E2/2, E2/3 29%; p=0038). Overall, the prevalence of any evidence of coronary heart disease among the subjects with the phenotypes E4/4 or E4/3 was 81% (p=0011 com.pared with other phenotypes), 58% in subjects with the phenotype E3/3, and 53% in subjects with phenotypes E2/2 or E2/3.
Discussion
The apolipoprotein E phenotypes E4/4 and E4/3 were strongly associated with coronary heart disease in non-insulin dependent diabetic men. This is a new finding which could explain, at least in part, the increased risk of coronary heart disease in patients with non-insulin dependent diabetes.
The evidence that the apolipoprotein E polymorphism modulates susceptibility to atherosclerotic vascular disease in people without diabetes is controversial. Some studies,2126 but not all,27 have shown a significant increase in the frequency of the e4 allele in the survivors of myocardial infarction or in the patients with angiographically verified coronary heart disease. Furthermore, the allele e4 has been observed-to increase the risk of myocardial infarction at an early age.28 These studies, however, have not included representative samples of non-diabetic population but highly selective groups of patients with established coronary heart disease. Differences in the prevalences of the e4 allele and coronary heart disease between populations also support the role of the e4 allele as a risk indicator for atherosclerosis. The Finns have exceptionally high prevalences of the e4 allele2029 and coronary heart disease7 whereas in the Chinese`0 and Japanese3' populations the e4 allele is relatively uncommon, as is coronary heart disease.
ROLE OF E4 ALLELE Why should people with non-insulin dependent diabetes be particularly susceptible to coronary heart disease if they happen to fall into the e4 allele category? Firstly, relatively high frequency of the apolipoprotein E phenotypes E4/4 and E4/3 in people with non-insulin dependent diabetes could lead to an increased risk of coronary heart disease. The distribution of the apolipoprotein E phenotypes in subjects with and without diabetes, however, was similar in our study and some other studies.32M34 Secondly, the risk for coronary heart disease could be related to the impact of the apolipoprotein E phenotypes on serum lipid and lipoprotein concentrations. Apolipoprotein E participates in the conversion of very low density lipoprotein remnants to low density lipoprotein, and this metabolic pathway is particularly effective in subjects with the e4 allele, which might result in a higher rate ofproduction of low density lipoprotein in these subjects.' 35 Furthermore, a high density lipoprotein subfraction containing apolipoprotein E is considered to play an important part in the reverse cholesterol transport,36 although the underlying mechanisms are poorly understood. Also subjects with the e4 allele have higher total and low density lipoprotein cholesterol concentrations,25 which increase the risk of coronary heart disease in the nondiabetic population.
High low density lipoprotein concentrations in people with the e4 allele seem to be related to the particularly effective absorption of cholesterol in these subjects,29 which may be one explanation for the differences in low density lipoprotein concentrations among people with the various apolipoprotein E phenotypes. We found that total and low density lipoprotein cholesterol concentrations were higher in diabetic subjects with the e4 allele than in subjects with the e2 allele, confirming the findings of some previous studies.3233 The low density lipoprotein cholesterol concentration of the subjects with phenotype E3/3 (62% of the study population) was similar to that in subjects with the e4 allele and higher than that in the BMJ VOLUME 303subjects with the e2 allele. But subjects with the E3/3 allele and non-insulin dependent diabetes still had a lower rate of coronary heart disease manifestations than those with the e4 allele.
No differences in other cardiovascular risk factors (smoking, hypertension, obesity, physical activity) were found between the different apolipoprotein E phenotypes ( 
